Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding
2 other identifiers
interventional
40
1 country
1
Brief Summary
This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding interventions to enhance both cancer prevention behaviors. The investigators will recruit 40 daily smoking women in their early pregnancy and randomize them into the integrated intervention or control group. Main outcomes include smoking abstinence and breastfeeding rates at 6 months postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedResults Posted
Study results publicly available
April 17, 2025
CompletedApril 17, 2025
April 1, 2025
2.8 years
October 26, 2021
March 17, 2025
April 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants With Smoking Abstinence
Based on their recorded daily numbers of cigarettes and cigars smoked after enrollment, the investigators will classify smoking abstinence status in the past 7 days (7-day point-prevalence). The self-reported smoking abstinence will be biochemically confirmed by urine cotinine tests (\<50 ng/mL).
6 months postpartum
Number of Participants With Reported Intent to Breastfeed
During pregnancy, participants will report breastfeeding intention using questionnaires modified from the Infant Feeding Practices Study II. The question is, "What method do you plan to use to feed your new baby in the first few weeks?" with 4 response options: 1) breastfeeding only (baby will not be given formula), 2) formula feed only, 3) both breastfeed and formula feed, or 4) unsure. We create a binary variable to indicate breastfeeding intentions (option 1 or 3) or other feeding intentions (option 2 or 4).
35 weeks of pregnancy (the end of pregnancy)
Number of Participants Reporting to Breastfeed
During postpartum, mothers report their breastfeeding status (exclusive, mixed with formula, non-breastfeeding) every month until 6 months postpartum. Any breastfeeding is defined as exclusive breastfeeding or mixed-feeding breast milk and formula.
6 months postpartum
Study Arms (2)
Integrated intervention
EXPERIMENTALIntegrated intervention of smoking cessation and breastfeeding
Attention placebo control group
ACTIVE COMPARATORInstructions on general pregnancy and infant care
Interventions
The intervention group will receive an integrated intervention of smoking cessation and breastfeeding: education and counseling, monitoring and feedback, and contingent financial incentives.
Participants in the control group will receive usual prenatal care from physicians, nurses, or social workers. They will receive best standard care on smoking cessation and breastfeeding, including referral to the New York State Smokers' Quitline and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).
Eligibility Criteria
You may qualify if:
- Be 18 years or older
- At ≤28 weeks of pregnancy
- Daily smoking cigarettes and/or cigars in the past 7 days
- Be able to read, listen, and talk in English
You may not qualify if:
- Being diagnosed with cancer
- Current heavy drinking (more than 2 drinks a day)
- Current use of illicit substances
- Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo
Buffalo, New York, 14214, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Xiaozhong Wen
- Organization
- State University of New York at Buffalo
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaozhong Wen, MD, PhD
State University of New York at Buffalo
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Research staff who collect and analyze outcome data will be blinded to participants' group assignments.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 26, 2021
First Posted
November 17, 2021
Study Start
January 1, 2021
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
April 17, 2025
Results First Posted
April 17, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share